Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-16

Clinical Trial Update: Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating creatine supplementation with resistance training to preserve muscle mass in metastatic prostate cancer. The study aims t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creatine (creatine)

Snippet

Sponsor: University of Utah | Conditions: Metastatic Prostate Cancer | Phase 3 | Status: RECRUITING